$COEP
Coeptis Therapeutics Holdings, Inc. Stock $coep

$coep Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000168316824005799 Filed on August 16, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$0.00	$0.00	$0.00
YoY Change
Gross Profit	$0.00	$0.00	$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$173.1K	$244.0K	$3.218M
YoY Change	-93.88%	-92.42%	-66.99%
% of Gross Profit
Research & Development	$811.8K	$398.8K	$377.0K
YoY Change	-83.71%	5.78%
% of Gross Profit
Depreciation & Amortization			$250.3K
YoY Change			-0.01%
% of Gross Profit
Operating Expenses	$2.142M	$2.828M	$3.638M
YoY Change	-72.65%	-22.26%	326.59%
Operating Profit	-$2.142M	-$2.828M	-$3.638M
YoY Change	-72.65%	-22.26%	-62.93%
Interest Expense		$66.06K	$42.64K
YoY Change		54.93%	-13.74%
% of Operating Profit
Other Income/Expense, Net	$312.9K	-$207.2K	$525.0K
YoY Change	-80.08%	-139.47%	-12.3%
Pretax Income	-$1.829M	-$3.035M	-$3.113M
YoY Change	-70.79%	-2.5%	1420.41%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.829M	-$3.035M	-$3.113M
YoY Change	-70.79%	-2.5%	1420.41%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.05	-$0.08	-$0.14
Diluted Earnings Per Share	-$0.05	-$0.08	-$0.14
COMMON SHARES
Basic Shares Outstanding	39.72M shares	37.12M shares	21.44M shares
Diluted Shares Outstanding	39.81M shares	37.57M shares	21.81M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments			$3.245M
YoY Change			3755.98%
Cash & Equivalents	$1.137M	$1.555M	$3.245M
Short-Term Investments
Other Short-Term Assets			$202.5K
YoY Change			421.86%
Inventory
Prepaid Expenses	$227.2K	$244.8K	$202.5K
Receivables			$0.00
Other Receivables			$0.00
Total Short-Term Assets	$1.365M	$1.991M	$3.797M
YoY Change	-66.88%	-47.57%	2988.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.67K	$10.88K	$11.92K
YoY Change	-8.12%	-8.73%	-86.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets			$3.308M
YoY Change
Total Long-Term Assets	$7.591M	$2.207M	$3.358M
YoY Change	148.87%	-34.27%	-89.82%
TOTAL ASSETS
Total Short-Term Assets	$1.365M	$1.991M	$3.797M
Total Long-Term Assets	$7.591M	$2.207M	$3.358M
Total Assets	$8.956M	$4.198M	$7.156M
YoY Change	24.9%	-41.33%	-78.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.134M	$1.281M	$395.2K
YoY Change	135.32%	224.15%	-58.35%
Accrued Expenses	$742.2K	$771.0K	$247.3K
YoY Change	148.84%	211.73%	-23.92%
Deferred Revenue
YoY Change
Short-Term Debt			$0.00
YoY Change
Long-Term Debt Due			$1.850M
YoY Change			-49.49%
Total Short-Term Liabilities	$3.440M	$3.626M	$2.514M
YoY Change	112.88%	44.23%	164.92%
LONG-TERM LIABILITIES
Long-Term Debt	$150.0K	$150.0K	$150.0K
YoY Change	0.0%	0.0%
Other Long-Term Liabilities			$2.002M
YoY Change			-36.5%
Total Long-Term Liabilities	$533.3K	$882.8K	$2.152M
YoY Change	-1.8%	-58.98%	-31.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.440M	$3.626M	$2.514M
Total Long-Term Liabilities	$533.3K	$882.8K	$2.152M
Total Liabilities	$3.974M	$4.508M	$4.666M
YoY Change	84.04%	-3.38%	13.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$95.22M	-$93.39M	-$76.72M
YoY Change	14.75%	21.73%
Common Stock	$3.997K	$3.972K	$2.440K
YoY Change	21.16%	62.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$0.00	$0.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.825M	-$442.6K	$2.490M
YoY Change
Total Liabilities & Shareholders Equity	$8.956M	$4.198M	$7.156M
YoY Change	24.9%	-41.33%	-78.39%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$1.829M	-$3.035M	-$3.113M
YoY Change	-70.79%	-2.5%	1420.41%
Depreciation, Depletion And Amortization			$250.3K
YoY Change			-0.01%
Cash From Operating Activities			-$1.903M
YoY Change			643.2%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities			-$350.0K
YoY Change			-100.82%
Cash From Investing Activities			-$350.0K
YoY Change			-100.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			3.391M
YoY Change			-107.95%
NET CHANGE
Cash From Operating Activities			-1.903M
Cash From Investing Activities			-350.0K
Cash From Financing Activities			3.391M
Net Change In Cash			1.138M
YoY Change			-1484.07%
FREE CASH FLOW
Cash From Operating Activities			-$1.903M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39669
	dei	Entity Registrant Name EntityRegistrantName	COEPTIS THERAPEUTICS HOLDINGS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 420
	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1465952
	dei	Entity Address Address Line1 EntityAddressAddressLine1	105 Bradford Rd
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wexford
	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	15090
	dei	City Area Code CityAreaCode	724
	dei	Local Phone Number LocalPhoneNumber	934-6467
CY2024Q2	us-gaap	Cash Cash	1555075	usd
CY2024Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	191082	usd
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	38978	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	244776	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	241601	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	1990933	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1749713	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25237	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10883	usd
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39718593	shares
CY2024Q2	us-gaap	Cash Cash	1555075	usd
CY2023Q4	us-gaap	Cash Cash	1469134	usd
CY2024Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	191082	usd
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	38978	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	244776	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	241601	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	1990933	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1749713	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25237	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25237	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14354	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13931	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10883	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11306	usd
CY2024Q2	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	63333	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	158333	usd
CY2024Q2	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	2054167	usd
CY2023Q4	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	2554166	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79104	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	97571	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	2196604	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	2810070	usd
CY2024Q2	us-gaap	Assets Assets	4198420	usd
CY2023Q4	us-gaap	Assets Assets	4571089	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1281152	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1419699	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	771035	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	555950	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1553929	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	975000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19560	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38047	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3625676	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2988696	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	150000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11306	usd
CY2024Q2	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	63333	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	158333	usd
CY2024Q2	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	2054167	usd
CY2023Q4	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	2554166	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79104	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	97571	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	2196604	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	2810070	usd
CY2024Q2	us-gaap	Assets Assets	4198420	usd
CY2023Q4	us-gaap	Assets Assets	4571089	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1281152	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1419699	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	771035	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	555950	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	975000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19560	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38047	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3625676	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2988696	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	150000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	150000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	557250	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61179	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61179	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	882804	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	768429	usd
CY2024Q2	us-gaap	Liabilities Liabilities	4508480	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3757125	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4300	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4300	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	2	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4300	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4300	shares
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	150000	usd
CY2024Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	671625	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	557250	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61179	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61179	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	882804	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	768429	usd
CY2024Q2	us-gaap	Liabilities Liabilities	4508480	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3757125	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4300	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4300	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	2	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39718593	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35331036	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3533	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	100496465	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	91666691	usd
CY2024Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	7600000	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	3500000	usd
CY2024Q2	coep	Common Stock Subscribed CommonStockSubscribed	50000	usd
CY2023Q4	coep	Common Stock Subscribed CommonStockSubscribed	0	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-87356260	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	813964	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	0	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	813964	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4571089	usd
CY2024Q2	us-gaap	Revenues Revenues	0	usd
CY2023Q2	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	0	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	0	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	0	usd
	us-gaap	Gross Profit GrossProfit	0	usd
	us-gaap	Gross Profit GrossProfit	0	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	398817	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39718593	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35331036	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35331036	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	3972	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3533	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	100496465	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	91666691	usd
CY2024Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	7600000	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	3500000	usd
CY2024Q2	coep	Common Stock Subscribed CommonStockSubscribed	50000	usd
CY2023Q4	coep	Common Stock Subscribed CommonStockSubscribed	0	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93392993	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	813964	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	132494	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	0	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-310060	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	813964	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4198420	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4571089	usd
CY2024Q2	us-gaap	Revenues Revenues	0	usd
CY2023Q2	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	0	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	0	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	0	usd
	us-gaap	Gross Profit GrossProfit	0	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	398817	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	466629	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1175886	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	581959	usd
CY2024Q2	us-gaap	Salaries And Wages SalariesAndWages	459099	usd
CY2023Q2	us-gaap	Salaries And Wages SalariesAndWages	355927	usd
	us-gaap	Salaries And Wages SalariesAndWages	904458	usd
	us-gaap	Salaries And Wages SalariesAndWages	639844	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	250000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	250000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	500000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	500000	usd
CY2023Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	2298224	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	611570	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	113391	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	708459	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	235692	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	239028	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	200513	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	411595	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	466629	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1175886	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	581959	usd
CY2024Q2	us-gaap	Salaries And Wages SalariesAndWages	459099	usd
CY2023Q2	us-gaap	Salaries And Wages SalariesAndWages	355927	usd
	us-gaap	Salaries And Wages SalariesAndWages	904458	usd
	us-gaap	Salaries And Wages SalariesAndWages	639844	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	250000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	250000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	500000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	500000	usd
CY2024Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	864588	usd
CY2023Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	2298224	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	2045087	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	7850310	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	611570	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	113391	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	708459	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	235692	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	239028	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	200513	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	411595	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	415831	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	300	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	300	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2828102	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	3684984	usd
	us-gaap	Operating Expenses OperatingExpenses	10223936	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2828102	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3684984	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5750485	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10223936	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	66056	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	42636	usd
	us-gaap	Interest Expense InterestExpense	266561	usd
	us-gaap	Interest Expense InterestExpense	74053	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8063	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2024Q2	coep	Change In Fair Value Of Derivative Liability Warrants ChangeInFairValueOfDerivativeLiabilityWarrants	-149250	usd
CY2023Q2	coep	Change In Fair Value Of Derivative Liability Warrants ChangeInFairValueOfDerivativeLiabilityWarrants	525000	usd
	coep	Change In Fair Value Of Derivative Liability Warrants ChangeInFairValueOfDerivativeLiabilityWarrants	-114375	usd
	coep	Change In Fair Value Of Derivative Liability Warrants ChangeInFairValueOfDerivativeLiabilityWarrants	-862500	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-207243	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3035345	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	415831	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	300	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2828102	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	3684984	usd
	us-gaap	Operating Expenses OperatingExpenses	5750485	usd
	us-gaap	Operating Expenses OperatingExpenses	10223936	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2828102	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3684984	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5750485	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10223936	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	66056	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	42636	usd
	us-gaap	Interest Expense InterestExpense	266561	usd
	us-gaap	Interest Expense InterestExpense	74053	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8063	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	94688	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	35	usd
CY2024Q2	coep	Change In Fair Value Of Derivative Liability Warrants ChangeInFairValueOfDerivativeLiabilityWarrants	-149250	usd
CY2023Q2	coep	Change In Fair Value Of Derivative Liability Warrants ChangeInFairValueOfDerivativeLiabilityWarrants	525000	usd
	coep	Change In Fair Value Of Derivative Liability Warrants ChangeInFairValueOfDerivativeLiabilityWarrants	-114375	usd
	coep	Change In Fair Value Of Derivative Liability Warrants ChangeInFairValueOfDerivativeLiabilityWarrants	-862500	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-207243	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	482364	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-286248	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3035345	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3202620	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11160454	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-3035345	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-3035345	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37569312	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37569312	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21808563	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21808563	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36551418	shares
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-3035345	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-3202620	usd
	us-gaap	Profit Loss ProfitLoss	-6036733	usd
	us-gaap	Profit Loss ProfitLoss	-11160454	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-3035345	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3202620	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11160454	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37569312	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37569312	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21808563	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21808563	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36551418	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36551418	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21080395	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21080395	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4453329	usd
CY2023Q1	coep	Stock Issued During Period Value Issued Subscribed For Non Employee Services StockIssuedDuringPeriodValueIssuedSubscribedForNonEmployeeServices	3116814	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1111706	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	122391	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7957833	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	846407	usd
CY2023Q2	coep	Stock Issued During Period Value Issued Subscribed For Non Employee Services StockIssuedDuringPeriodValueIssuedSubscribedForNonEmployeeServices	351000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	811500	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	113301	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3040861	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3202620	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1960449	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	813964	usd
CY2024Q1	coep	Stock Issued During Period Value Issued For Non Employee Services StockIssuedDuringPeriodValueIssuedForNonEmployeeServices	541750	usd
CY2024Q1	coep	Stock Issued During Period Value Warrants Issued For Cash StockIssuedDuringPeriodValueWarrantsIssuedForCash	500000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	8150	usd
CY2024Q1	coep	Warrants Issued In Exchange For Note Receivable Value WarrantsIssuedInExchangeForNoteReceivableValue	-100000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	96889	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3001388	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1140635	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	558350	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	952000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36551418	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21080395	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21080395	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4453329	usd
CY2023Q1	coep	Stock Issued During Period Value Issued Subscribed For Non Employee Services StockIssuedDuringPeriodValueIssuedSubscribedForNonEmployeeServices	3116814	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1111706	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	122391	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7957833	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	846407	usd
CY2023Q2	coep	Stock Issued During Period Value Issued Subscribed For Non Employee Services StockIssuedDuringPeriodValueIssuedSubscribedForNonEmployeeServices	351000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	811500	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	113301	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3040861	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3202620	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1960449	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	813964	usd
CY2024Q1	coep	Stock Issued During Period Value Issued For Non Employee Services StockIssuedDuringPeriodValueIssuedForNonEmployeeServices	541750	usd
CY2024Q1	coep	Stock Issued During Period Value Warrants Issued For Cash StockIssuedDuringPeriodValueWarrantsIssuedForCash	500000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	8150	usd
CY2024Q1	coep	Warrants Issued In Exchange For Note Receivable Value WarrantsIssuedInExchangeForNoteReceivableValue	-100000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	96889	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3001388	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1140635	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	558350	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	952000	usd
CY2024Q2	coep	Stock Issued During Period Value Of Preferred Share Offering StockIssuedDuringPeriodValueOfPreferredShareOffering	1744000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	611570	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-3035345	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-310060	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6036733	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11160454	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500422	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500619	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	150000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-114375	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-862500	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	708459	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	235692	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1100100	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	3467814	usd
	coep	Warrants Issued For Services WarrantsIssuedForServices	8150	usd
	coep	Warrants Issued For Services WarrantsIssuedForServices	1923206	usd
	coep	Loss On Shares Issued For Conversion Of Debt LossOnSharesIssuedForConversionOfDebt	77250	usd
	coep	Loss On Shares Issued For Conversion Of Debt LossOnSharesIssuedForConversionOfDebt	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8075	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-152104	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-91825	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-34880	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-20	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-415	usd
CY2024Q2	coep	Stock Issued During Period Value Of Preferred Share Offering StockIssuedDuringPeriodValueOfPreferredShareOffering	1744000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	611570	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-3035345	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-310060	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6036733	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11160454	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500422	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500619	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	150000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-114375	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-862500	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	708459	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	235692	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1100100	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	3467814	usd
	coep	Warrants Issued For Services WarrantsIssuedForServices	8150	usd
	coep	Warrants Issued For Services WarrantsIssuedForServices	1923206	usd
	coep	Loss On Shares Issued For Conversion Of Debt LossOnSharesIssuedForConversionOfDebt	77250	usd
	coep	Loss On Shares Issued For Conversion Of Debt LossOnSharesIssuedForConversionOfDebt	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8075	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-152104	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-91825	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-34880	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-20	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-138547	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	296211	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	256702	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	244521	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3320121	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3587351	usd
	coep	Increase In Subscription Receivable In Exchange For Cash IncreaseInSubscriptionReceivableInExchangeForCash	100000	usd
	coep	Increase In Subscription Receivable In Exchange For Cash IncreaseInSubscriptionReceivableInExchangeForCash	350000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-100000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-350000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1850000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	350000	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-587500	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	3040861	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	500000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	50000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
	coep	Preferred Stock Offering PreferredStockOffering	1693562	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3506062	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3390861	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	85941	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-546490	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1469134	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3791302	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1555075	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3244812	usd
	coep	Subscriptions Receivable SubscriptionsReceivable	4100000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-138547	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	296211	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	256702	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	244521	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3320121	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3587351	usd
	coep	Increase In Subscription Receivable In Exchange For Cash IncreaseInSubscriptionReceivableInExchangeForCash	100000	usd
	coep	Increase In Subscription Receivable In Exchange For Cash IncreaseInSubscriptionReceivableInExchangeForCash	350000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-100000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-350000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1850000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	350000	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-587500	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	3040861	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	500000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	50000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
	coep	Preferred Stock Offering PreferredStockOffering	1693562	usd
	coep	Preferred Stock Offering PreferredStockOffering	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3506062	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3390861	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	85941	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-546490	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1469134	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3791302	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1555075	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3244812	usd
	coep	Subscriptions Receivable SubscriptionsReceivable	4100000	usd
	coep	Subscriptions Receivable SubscriptionsReceivable	0	usd
	coep	Shares Issued For Conversion Of Debt SharesIssuedForConversionOfDebt	868750	usd
	coep	Shares Issued For Conversion Of Debt SharesIssuedForConversionOfDebt	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zXi8GfPJQ0va" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_867_zVd0xhY6OLp5">Use of Estimates</span> –</b> The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	coep	Subscriptions Receivable SubscriptionsReceivable	0	usd
	coep	Shares Issued For Conversion Of Debt SharesIssuedForConversionOfDebt	868750	usd
	coep	Shares Issued For Conversion Of Debt SharesIssuedForConversionOfDebt	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zXi8GfPJQ0va" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_867_zVd0xhY6OLp5">Use of Estimates</span> –</b> The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zJL1dY4y5lH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassifications – </b>During the six months ended June 30, 2024, the Company reclassified certain Note receivables to Subscription receivables. As a result, $5,500,000 was reclassified on the Company’s Condensed Consolidated Balance Sheet as of June 30, 2024. The comparative figures for the year ended December 31, 2023 have been adjusted accordingly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93392993	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6036733	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	218750	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	625000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93392993	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	218750	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	625000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1553929	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1687	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	3266	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	145047	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	1703929	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1553929	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1687	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	3266	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	145047	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	1703929	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39718593	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39718593	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35331036	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35331036	shares
CY2024Q2	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	0	usd
	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	0	usd
CY2023Q2	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	0	usd
	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	0	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	0	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4300	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4300	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39718593	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39718593	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35331036	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35331036	shares
CY2024Q2	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	0	usd
	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	0	usd
CY2023Q2	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	0	usd
	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	0	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	0	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4300	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4300	shares
	coep	Investors Shares Description InvestorsSharesDescription	On June 14, 2024, the Company performed an initial closing and raised $4.3 million in a sale to accredited investors (collectively, the “Series A Investors”) of 4,300 shares of the Company’s series A preferred stock (the “Series A Preferred Stock”), at a purchase price of $1,000 per share, in a financing led by CJC Investment Trust
CY2024Q2	coep	Non Voting Equity Ownership Interest NonVotingEquityOwnershipInterest	0.0645	pure
CY2024Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1000	shares
CY2024Q2	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.40
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	20000000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1029725	usd
	coep	Investors Shares Description InvestorsSharesDescription	On June 14, 2024, the Company performed an initial closing and raised $4.3 million in a sale to accredited investors (collectively, the “Series A Investors”) of 4,300 shares of the Company’s series A preferred stock (the “Series A Preferred Stock”), at a purchase price of $1,000 per share, in a financing led by CJC Investment Trust
CY2024Q2	coep	Non Voting Equity Ownership Interest NonVotingEquityOwnershipInterest	0.0645	pure
CY2024Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1000	shares
CY2024Q2	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.40
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	20000000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1029725	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	16703160	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13232043	shares
CY2023Q4	coep	Warrants Exercisable To Acquire WarrantsExercisableToAcquire	1200000	shares
CY2023Q4	coep	Warrants Exercisable To Acquire Amount WarrantsExercisableToAcquireAmount	1000000	usd
	coep	Amendment Decription AmendmentDecription	The amount of pre-funded warrants exercisable to acquire up to 1,200,000 shares of common stock was amended to 2,000,000 shares of common stock, and the total principal balance of the note agreement was increased from $1,000,000 to $1,100,000. The $1,100,000 outstanding receivable balance is recorded as subscription receivable, a contra equity account within stockholders’ equity (deficit) at June 30, 2024.
CY2024Q1	coep	Warrants Exercisable To Acquire WarrantsExercisableToAcquire	4000000	shares
CY2024Q1	coep	Warrants Exercisable To Acquire Amount WarrantsExercisableToAcquireAmount	1900000	usd
CY2024Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	1900000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	132494	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	11250	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	22555	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22830	usd
	coep	Investors Shares Description InvestorsSharesDescription	On June 14, 2024, the Company performed an initial closing and raised $4.3 million in a sale to accredited investors (collectively, the “Series A Investors”) of 4,300 shares of the Company’s series A preferred stock (the “Series A Preferred Stock”), at a purchase price of $1,000 per share, in a financing led by CJC Investment Trust
CY2024Q2	coep	Non Voting Equity Ownership Interest NonVotingEquityOwnershipInterest	0.0645	pure
CY2024Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1000	shares
CY2024Q2	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.40
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	20000000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1029725	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	16703160	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13232043	shares
CY2023Q4	coep	Warrants Exercisable To Acquire WarrantsExercisableToAcquire	1200000	shares
CY2023Q4	coep	Warrants Exercisable To Acquire Amount WarrantsExercisableToAcquireAmount	1000000	usd
	coep	Amendment Decription AmendmentDecription	The amount of pre-funded warrants exercisable to acquire up to 1,200,000 shares of common stock was amended to 2,000,000 shares of common stock, and the total principal balance of the note agreement was increased from $1,000,000 to $1,100,000. The $1,100,000 outstanding receivable balance is recorded as subscription receivable, a contra equity account within stockholders’ equity (deficit) at June 30, 2024.
CY2024Q1	coep	Warrants Exercisable To Acquire WarrantsExercisableToAcquire	4000000	shares
CY2024Q1	coep	Warrants Exercisable To Acquire Amount WarrantsExercisableToAcquireAmount	1900000	usd
CY2024Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	1900000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	132494	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	11250	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	22555	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22830	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	16703160	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13232043	shares
CY2023Q4	coep	Warrants Exercisable To Acquire WarrantsExercisableToAcquire	1200000	shares
CY2023Q4	coep	Warrants Exercisable To Acquire Amount WarrantsExercisableToAcquireAmount	1000000	usd
	coep	Amendment Decription AmendmentDecription	The amount of pre-funded warrants exercisable to acquire up to 1,200,000 shares of common stock was amended to 2,000,000 shares of common stock, and the total principal balance of the note agreement was increased from $1,000,000 to $1,100,000. The $1,100,000 outstanding receivable balance is recorded as subscription receivable, a contra equity account within stockholders’ equity (deficit) at June 30, 2024.
CY2024Q1	coep	Warrants Exercisable To Acquire WarrantsExercisableToAcquire	4000000	shares
CY2024Q1	coep	Warrants Exercisable To Acquire Amount WarrantsExercisableToAcquireAmount	1900000	usd
CY2024Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	1900000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	132494	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	11250	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	22555	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22830	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	46101	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	19301	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	88232	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	80739	usd
CY2023Q3	coep	Agreement Amendment Fee AgreementAmendmentFee	2000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	46101	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	19301	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	88232	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7493	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	80739	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79104	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19560	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61179	usd
CY2024Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
CY2023Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	88232	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7493	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	80739	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79104	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61179	usd
CY2023Q3	coep	Agreement Amendment Fee AgreementAmendmentFee	2000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
CY2023Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
CY2023Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-005799-index-headers.html	Edgar Link	pending
0001683168-24-005799-index.html	Edgar Link	pending
0001683168-24-005799.txt	Edgar Link	pending
0001683168-24-005799-xbrl.zip	Edgar Link	pending
coep-20240630.xsd	Edgar Link	pending
coeptis_ex3101.htm	Edgar Link	pending
coeptis_ex3102.htm	Edgar Link	pending
coeptis_ex3201.htm	Edgar Link	pending
coeptis_ex3202.htm	Edgar Link	pending
coeptis_i10q-063024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
coep-20240630_def.xml	Edgar Link	unprocessable
coep-20240630_lab.xml	Edgar Link	unprocessable
coep-20240630_cal.xml	Edgar Link	unprocessable
coep-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
coeptis_i10q-063024_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
0001683168-24-005799-index-headers.html	Edgar Link	pending
0001683168-24-005799-index.html	Edgar Link	pending
0001683168-24-005799.txt	Edgar Link	pending
0001683168-24-005799-xbrl.zip	Edgar Link	pending
coep-20240630.xsd	Edgar Link	pending
coeptis_ex3101.htm	Edgar Link	pending
coeptis_ex3102.htm	Edgar Link	pending
coeptis_ex3201.htm	Edgar Link	pending
coeptis_ex3202.htm	Edgar Link	pending
coeptis_i10q-063024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
coep-20240630_lab.xml	Edgar Link	unprocessable
coep-20240630_def.xml	Edgar Link	unprocessable
coep-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
coeptis_i10q-063024_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
coep-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COEP
Coeptis Therapeutics Holdings, Inc. Stock $coep

2024 Q3 Form 10-Q Financial Statement

#000168316824005799 Filed on August 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COEP Coeptis Therapeutics Holdings, Inc. Stock $coep

2024 Q3 Form 10-Q Financial Statement

#000168316824005799 Filed on August 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COEP
Coeptis Therapeutics Holdings, Inc. Stock $coep